Compare Adaptive Biotechnologies Corp (ADPT) vs Home Depot Inc (HD) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Adaptive Biotechnologies Corp vs Home Depot Inc — how do they compare? Adaptive Biotechnologies Corp trades at $25.5 (market cap $4.04B), while Home Depot Inc trades at $354 (market cap $353.46B). The key difference: Home Depot Inc is far larger — about 87.5× Adaptive Biotechnologies Corp's market cap, and Home Depot Inc pays a 2.63% dividend while Adaptive Biotechnologies Corp pays none. Which is the better fit depends on your goals.
| ADPT | HD | |
|---|---|---|
Market Cap | $4.04B | $353.46B |
Sector | Health | Consumer Cyclical |
52-Week High | $25.45 | $423.42 |
52-Week Low | $12.30 | $297.51 |
Enterprise Value | $4.10B | $415.01B |
Dividend Yield | — | 2.63% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Home Depot (HD) trades at $350.78, down 1.36% on the day, with a bullish technical outlook supported by moving averages. The company reported mixed quarterly earnings, missing in Q3 2025 but beating in Q4 2025 and Q1 2026. Strong profitability metrics include a 33.13% gross margin and 128.38% ROE, though net margins have declined from 10.87% in 2022 to 8.41% in 2026. Recent news highlights institutional trading activity and concerns about weakening big-ticket demand amid rising mortgage rates.
The stock offers a 6% upside to the consensus price target of $371.25, with 59% of analysts rating it Buy. Key risks include housing market sensitivity and margin pressure from investments. Long-term growth drivers include Pro customer focus and digital expansion, but near-term headwinds from economic conditions warrant caution.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Adaptive Biotechnologies Corp
Adaptive Biotechnologies Corp is a commercial-stage company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is test authorized by the FDA for the detection and monitoring of minimal residual disease in patients with select blood cancers.
Read more on ADPT →About Home Depot Inc
Home Depot is the world's largest home improvement specialty retailer, operating more than 2,300 warehouse-format stores offering more than 30,000 products in store and 1 million products online in the United States, Canada, and Mexico. Its stores offer numerous building materials, home improvement products, lawn and garden products, and decor products and provide various services, including home improvement installation services and tool and equipment rentals. The acquisition of distributor Interline Brands in 2015 allowed Home Depot to enter the maintenance, repair, and operations business, which has been expanded through the tie-up with HD Supply (2020). The addition of the Company Store brought textile exposure to Home Depot's lineup.
Read more on HD →
